arthritis cure pet
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study evaluating resminostat (4SC-201), an oral pan ...Read more
4SC Announces First Patient Treated in a Phase II Hodgkin's Lymphoma ... - Stockhouse
Detailed information on the clinical trial can be found at http://www ... sites will be conducted during the Phase 2 psoriasis trial to evaluate the effect of VB-201 on atherosclerosis in psoriasis patients. PET-CT scans of the great vessels of the ...Read more
VBL Therapeutics Initiates Phase 2 Clinical Trial Of VB-201 In ... - Medical News Today
Read more